Tag: ACC 2023
Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease
Immediate, complete revascularisation with percutaneous coronary intervention (PCI) in patients ...
ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI
Assessing myocardial viability does not aid the selection of patients who will benefit—or not—fr...
ACC 2023: Equivalent recovery times shown between minimally invasive and conventional surgery for mitral valve repair
The largest randomised controlled trial to date to compare minimally invasive and conventional c...
ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions
Use of intravascular imaging guidance for percutaneous coronary intervention (PCI) in patients with ...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with ...
ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients
Three-year results from the Evolut Low Risk trial have shown “durable” benefits of transcatheter...
ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...
